These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 16184031

  • 1. MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells.
    Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ.
    AIDS; 2005 Oct 14; 19(15):1617-25. PubMed ID: 16184031
    [Abstract] [Full Text] [Related]

  • 2. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
    Woodahl EL, Crouthamel MH, Bui T, Shen DD, Ho RJ.
    Cancer Chemother Pharmacol; 2009 Jun 14; 64(1):183-8. PubMed ID: 19123050
    [Abstract] [Full Text] [Related]

  • 3. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein.
    Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ.
    J Pharmacol Exp Ther; 2004 Sep 14; 310(3):1199-207. PubMed ID: 15100388
    [Abstract] [Full Text] [Related]

  • 4. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
    van der Sandt IC, Vos CM, Nabulsi L, Blom-Roosemalen MC, Voorwinden HH, de Boer AG, Breimer DD.
    AIDS; 2001 Mar 09; 15(4):483-91. PubMed ID: 11242145
    [Abstract] [Full Text] [Related]

  • 5. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L, Eagling VA, Back DJ.
    AIDS; 1999 Sep 10; 13(13):1623-7. PubMed ID: 10509562
    [Abstract] [Full Text] [Related]

  • 6. Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs.
    Peng R, Zhang H, Zhang Y, Wei DY.
    Xenobiotica; 2016 Oct 10; 46(10):948-52. PubMed ID: 26822676
    [Abstract] [Full Text] [Related]

  • 7. The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro.
    Chandler B, Almond L, Ford J, Owen A, Hoggard P, Khoo S, Back D.
    J Acquir Immune Defic Syndr; 2003 Aug 15; 33(5):551-6. PubMed ID: 12902797
    [Abstract] [Full Text] [Related]

  • 8. Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.
    Polli JW, Jarrett JL, Studenberg SD, Humphreys JE, Dennis SW, Brouwer KR, Woolley JL.
    Pharm Res; 1999 Aug 15; 16(8):1206-12. PubMed ID: 10468021
    [Abstract] [Full Text] [Related]

  • 9. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
    Patel J, Buddha B, Dey S, Pal D, Mitra AK.
    Am J Ther; 2004 Aug 15; 11(4):262-77. PubMed ID: 15266218
    [Abstract] [Full Text] [Related]

  • 10. Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir.
    Luo S, Wang Z, Patel M, Khurana V, Zhu X, Pal D, Mitra AK.
    Int J Pharm; 2011 Jul 29; 414(1-2):77-85. PubMed ID: 21571053
    [Abstract] [Full Text] [Related]

  • 11. Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs.
    Huisman MT, Smit JW, Crommentuyn KM, Zelcer N, Wiltshire HR, Beijnen JH, Schinkel AH.
    AIDS; 2002 Nov 22; 16(17):2295-301. PubMed ID: 12441801
    [Abstract] [Full Text] [Related]

  • 12. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers.
    Alsenz J, Steffen H, Alex R.
    Pharm Res; 1998 Mar 22; 15(3):423-8. PubMed ID: 9563072
    [Abstract] [Full Text] [Related]

  • 13. Saquinavir induces stable and functional expression of the multidrug transporter P-glycoprotein in human CD4 T-lymphoblastoid CEMrev cells.
    Dupuis ML, Flego M, Molinari A, Cianfriglia M.
    HIV Med; 2003 Oct 22; 4(4):338-45. PubMed ID: 14525546
    [Abstract] [Full Text] [Related]

  • 14. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S.
    Biochemistry; 1998 Mar 17; 37(11):3594-601. PubMed ID: 9530286
    [Abstract] [Full Text] [Related]

  • 15. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor.
    Agarwal S, Pal D, Mitra AK.
    Int J Pharm; 2007 Jul 18; 339(1-2):139-47. PubMed ID: 17451894
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of human immunodeficiency virus protease inhibitors on multidrug resistance transporter P-glycoproteins.
    Shiraki N, Hamada A, Yasuda K, Fujii J, Arimori K, Nakano M.
    Biol Pharm Bull; 2000 Dec 18; 23(12):1528-31. PubMed ID: 11145192
    [Abstract] [Full Text] [Related]

  • 17. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells.
    Salama NN, Yang Z, Bui T, Ho RJ.
    J Pharm Sci; 2006 Oct 18; 95(10):2293-308. PubMed ID: 16883550
    [Abstract] [Full Text] [Related]

  • 18. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?
    Jones K, Bray PG, Khoo SH, Davey RA, Meaden ER, Ward SA, Back DJ.
    AIDS; 2001 Jul 27; 15(11):1353-8. PubMed ID: 11504956
    [Abstract] [Full Text] [Related]

  • 19. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
    Washington CB, Duran GE, Man MC, Sikic BI, Blaschke TF.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov 01; 19(3):203-9. PubMed ID: 9803961
    [Abstract] [Full Text] [Related]

  • 20. Transport of HIV-protease inhibitors across 1 alpha,25di-hydroxy vitamin D3-treated Calu-3 cell monolayers: modulation of P-glycoprotein activity.
    Patel J, Pal D, Vangal V, Gandhi M, Mitra AL.
    Pharm Res; 2002 Nov 01; 19(11):1696-703. PubMed ID: 12458676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.